AstraZeneca COVID-19 Vaccine showed no increased incidence of thrombosis with thrombocytopenia after second dose Incidence rates were comparable to those among unvaccinated individuals Analysis of rare cases from global safety database published in The Lancet  Rates of the very rare clotting disorder, thrombosis with thrombocytopenia syndrome (TTS), following a secondContinue Reading